Abstract

Objective: Although CMV is the most common congenital infection, studies on how its importance is understood by healthcare professionals are limited. This research aims to assess awareness and knowledge of pediatricians regarding congenital CMV infection (cCMVi).

Material and Methods: The target group of the study was pediatricians in Turkey. A 26-item anonymous questionnaire was developed, and implemented online. Participants were grouped by their professional seniority: Group-I, pediatric residents; Group-II, pediatricians; Group-III, specialists in any sub-branches of pediatrics; Group-IV, associate professors/professors in pediatrics.


Results: The questionnaire was completed by 434 respondents. The mean duration of practice was 11.95±7.3 (1-40) years for professionals, and 31.14±13.1 (1-60) months for pediatric residents. Of the participants, 85.9% knew that cCMVi screening is not applied in Turkey and 89.4% had previously followed a patient with suspected cCMVi. Incorrect answers regarding transmission routes and diagnosis methods were significantly more preferred by pediatricians other than residents. Correct answer rates about most common clinical presentation, imaging modalities, common disease-related sequelae, and treatment were generally quite low.


Conclusion: The responses revealed a lack of knowledge and awareness about cCMVi in Turkey among pediatricians, especially in professionals rather than residents. It is important to provide regular and ongoing training about cCMVi in countries where screening is not implemented.

Keywords: Awareness, Knowledge, Pediatrician, Screening, Congenital Cytomegalovirus infection

References

  1. Pesch MH, Schleiss MR. Emerging Concepts in Congenital Cytomegalovirus. Pediatrics 2022;150:e2021055896.
  2. Dobbins GC, Patki A, Chen D, Tiwari HK, Hendrickson C, Britt WJ, et al. Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection. BMC Infect Dis 2019;19:1046.
  3. Leruez-Ville M, Ville Y. Is it time for routine prenatal serological screening for congenital cytomegalovirus? Prenat Diagn 2020;40:1671-80.
  4. Kabani N, Ross SA. Congenital Cytomegalovirus Infection. J Infect Dis 2020;221(Suppl 1):S9-14.
  5. Ross SA, Kimberlin D. Clinical outcome and the role of antivirals in congenital cytomegalovirus infection. Antiviral Res 2021;191:105083.
  6. Chiopris G, Veronese P, Cusenza F, Procaccianti M, Perrone S, Daccò V, et al. Congenital Cytomegalovirus Infection: Update on Diagnosis and Treatment. Microorganisms 2020;8:1516.
  7. Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG,et al. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015;372:933-43.
  8. Hosseinzadeh Adli A, Karami C, Baghban Rahimi S, Mirarab A, Tabarraei A. What family doctors know about congenital CMV: a regional survey in Iran. Ital J Pediatr 2018;44:31.
  9. Korver AM, de Vries JJ, de Jong JW, Dekker FW, Vossen AC, Oudesluys-Murphy AM. Awareness of congenital cytomegalovirus among doctors in the Netherlands. J Clin Virol 2009;46:S11-5.
  10. Fellah T, Sibiude J, Vauloup-Fellous C, Cordier AG, Guitton S, Grangeot-Keros L, et al. Evolution of awareness and knowledge of congenital cytomegalovirus infection among health care providers in France between 2011 and 2018. J Clin Virol 2020;129:104335.
  11. Okahashi A, Kobayashi M, Okuyama K, Hiraishi N, Morioka I. Survey of physician knowledge of congenital cytomegalovirus infection and clinical practices in Japan: A web-based survey. Medicine (Baltimore) 2021;100:e27589.
  12. Pesch MH, Anderson C, Mowers E. Improving Obstetric Provider Congenital Cytomegalovirus Knowledge and Practices. Infect Dis Obstet Gynecol 2020;2020:8875494.
  13. Dedhia K, Tomlinson J, Murray N, Park A. Congenital Cytomegalovirus and Hearing Loss: A Pilot Cross-Sectional Survey of Otologists’ and Pediatric Otolaryngologists’ Knowledge. OTO Open 2019;3:2473974X19849874.
  14. Şahiner F. Konjenital Sitomegalovirüs Enfeksiyonlarının Tanı ve Yönetiminde Güncel Yaklaşımlar ve Türkiye’deki Durum [Current Approaches in the Diagnosis and Management of Congenital
  15. Cytomegalovirus Infections and the Situation in Turkey]. Mikrobiyol Bul 2020;54:171-90.
  16. Coppola T, Mangold JF, Cantrell S, Permar SR. Impact of Maternal Immunity on Congenital Cytomegalovirus Birth Prevalence and Infant Outcomes: A Systematic Review. Vaccines (Basel) 2019;7:129.
  17. Muldoon KM, Armstrong-Heimsoth A, Thomas J. Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States. PLoS One 2017;12:e0185635.
  18. Baer HR, McBride HE, Caviness AC, Demmler-Harrison GJ. Survey of congenital cytomegalovirus (cCMV) knowledge among medical students. J Clin Virol 2014;60:222-42.
  19. Nicloux M, Peterman L, Parodi M, Magny JF. Outcome and management of newborns with congenital cytomegalovirus infection. Arch Pediatr 2020 ;27:160-5.
  20. American Academy of Pediatrics. Cytomegalovirus infection. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, (eds). Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. American Academy of Pediatrics: Itasca; IL 2018:310.

Copyright and license

How to cite

1.
Kanık Yüksek S. The Importance of Regular and Ongoing Training For Congenital CMV in Countries Without Routine Screening: A Survey Among Pediatricians. Turk J Pediatr Dis [Internet]. 2023 May 29 [cited 2025 May 25];17(3):175-81. Available from: https://turkjpediatrdis.org/article/view/969